All.Proactive Investors videos with CytoDyn's CEO Nader Pourhassan and CMO Richard Pestell (developing drug leronlimab).
$CYDY #CYDY #PRO140 CYDY #leronlimab CytoDyn #HIV CCR5 #CCR5 #TNBC #ProstateCancer #IncellDx #GvHD #NASH #PrEP #Cancer #AIDS #coloncancer #metastaticcancer #breastcancer #triplenegativebreastcancer #RheumatoidArthritis‎ #MultipleSclerosis

CytoDyn to meet with FDA on prostate-cancer test, applies HIV screening test to monotherapy trial
June 21, 2019-- NP at ASM conference hotel

https://youtu.be/xgRbNC13wZc

CytoDyn CEO talks about latest HIV trial featuring its flagship drug, leronlimab
June 17, 2019--NP Office

https://youtu.be/R_iNJnHckC4

CytoDyn CEO responds to share price rise as investors get excited about leronlimab
June 12, 2019--NP in hotel (D.C.?)

https://youtu.be/KeW2ruS_eoQ

CytoDyn to meet with FDA to finalize next steps on leronlimab drug trial for HIV
June 7, 2019--NP at hotel

https://youtu.be/-5i1WQWcL2w

CytoDyn shows value of company lies in their research and technology
June 4, 2019--NP and RP LD Micro in LA

https://youtu.be/iO0A9ePT0Ns

CytoDyn updates investors on licensing agreement potentials at shareholders meeting
May 28, 2019--NP in hotel

https://youtu.be/LDkhLOMBvs0

CytoDyn takes major step forward filing trial protocol for HIV Monotherapy
May 16, 2019--NP in hotel

https://youtu.be/H3SaJmTbJxw


CytoDyn adds new talent to its management team
May 14, 2019-- RP & NP in hotel

https://youtu.be/EeoaQtzOm10

CytoDyn to begin proof-of-concept studies for leronlimab to treat liver damage caused by NASH
May 13, 2019--NP in hotel

https://youtu.be/hVwA4RlON18

CytoDyn reports positive preclinical data, gets FDA's fast-track designation
May 8, 2019 RP & NP in studio

https://youtu.be/6JWnMmxHbY0

CytoDyn sees progress with leronlimab to treat HIV-infected patients
May 7, 2019--NP in hotel

https://youtu.be/6JWnMmxHbY0

Cytodyn has raised over 190 million dollars as they look to commercialize lead drug
May 2, 2019--NP ThinkEquity NY

https://youtu.be/4GSlo8E-SGs

CytoDyn CEO updates timeline for HIV drug, addresses share dilution concerns
April 15, 2019--NP in office

https://youtu.be/R9Js5eqOcxQ


CytoDyn teams with Samsung BioLogics, presents key data at cancer research meeting
April 4, 2019--NP in hotel and RP

https://youtu.be/VrSOs_9YVv4

CytoDyn more than doubles recovery rate in its monotherapy HIV trial
March 27, 2019 -- NP in Studio

https://youtu.be/0a4y91iTv5s

CytoDyn's HIV drug leromlimab takes a big step forward
March 18, 2019--NP syke hotel

https://youtu.be/iPrdhL7hIdc


CytoDyn files for fast-track designation for leronlimab in breast cancer treatment
March 11, 2019-- NP in office

https://youtu.be/SDMJZRqh9Ws

CytoDyn presents 'stunning' data on treatment of HIV at Seattle conference
March 08, 2019-- NP in office, RP

https://youtu.be/BwN0J3Hb4sU

FDA accepted CytoDyn’s request and plan to submit BLA on rolling basis
March 4, 2019-- NP in hotel

https://youtu.be/Ya-q20FI22Y


CytoDyn files for Orphan Drug designation to treat triple-negative breast cancer
February 21, 2019-- NP in office, RP

https://youtu.be/qh5dH7_vvWc

CytoDyn to begin preclinical studies with leronlimab for 8 different cancers
February 19, 2019-- NP & RP skype

https://youtu.be/2dc1UDDSZuY

CytoDyn CEO says FDA has offered 'a good path forward' for its HIV drug
February 5, 2019-- NP in studio

https://youtu.be/Hq27_b2loEs


CytoDyn aims to be 'paradigm-shifting' in cancer management with its platform drug leronlimab [/b
January 11, 2019-- NP & RP Bioconf San Fran.

https://youtu.be/gQWe6FXL3wk